Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
NeuroSense Therapeutics Ltd (NASDAQ: NRSN) closed the day trading at $0.93 up 3.31% from the previous closing price of $0.90. In other words, the price has increased by $3.31 from its previous closing price. On the day, 0.15 million shares were traded. NRSN stock price reached its highest trading level at $0.95 during the session, while it also had its lowest trading level at $0.8006.
Ratios:
For a better understanding of NRSN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.46 and its Current Ratio is at 0.46.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRSN now has a Market Capitalization of 19255692 and an Enterprise Value of 15615671.
Stock Price History:
Over the past 52 weeks, NRSN has reached a high of $2.33, while it has fallen to a 52-week low of $0.51. The 50-Day Moving Average of the stock is -21.76%, while the 200-Day Moving Average is calculated to be -22.90%.
Shares Statistics:
Over the past 3-months, NRSN traded about 237.29K shares per day on average, while over the past 10 days, NRSN traded about 140250 shares per day. A total of 20.71M shares are outstanding, with a floating share count of 15.47M. Insiders hold about 25.29% of the company’s shares, while institutions hold 1.09% stake in the company. Shares short for NRSN as of 1731628800 were 258123 with a Short Ratio of 1.09, compared to 1728950400 on 235717. Therefore, it implies a Short% of Shares Outstanding of 258123 and a Short% of Float of 1.54.
